| Betterchem |

|
|
| FDA approval activities
for this prescription drug:
Infasurf (calfactant) Intratracheal Suspension, , ONY NDA 20-521 7/1/1998 7/2/98 7/2/98 4/11/02 Infasurf Indication: for the prevention and treatment of Respiratory Distress Syndrome (RDS) in neonates. |
|
© 2009 Betterchem.com
|